| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/01/2004 | CN1164297C Use of kudzu root ,kudzu root flavone and puerarin for prevention and cure of osteoporosis |
| 09/01/2004 | CN1164279C Mixed live bacillus drops of bifidobacterium and lactobacillaceau and its prepn |
| 09/01/2004 | CN1164273C Natural oral liquor for treatment of women's climacteric syndrome |
| 08/31/2004 | US6784185 Pharmaceutically active compounds |
| 08/31/2004 | US6784183 Diphenylurea compounds |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |
| 08/26/2004 | WO2004072083A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 08/26/2004 | WO2004071508A1 Ip receptor antagonists for the treatment of pathological uterine conditions |
| 08/26/2004 | WO2004071427A2 Screening and treatment methods for prevention of preterm delivery |
| 08/26/2004 | WO2004071390A2 Piperazine-2-carboxamide derivatives |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167137 Xanthine phosphodiesterase V inhibitors |
| 08/26/2004 | US20040167133 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/26/2004 | US20040167064 Materials and methods relating for the treatment and diagnosis of pre-eclampsia |
| 08/26/2004 | US20040167039 containing polyol(s) and a gelling agent; increases in temperature by at least 5 degrees C. upon exposure to moisture and which has a Maximum Energy Release Index of at least 11 mJ/mg.; use for vaginal lubrication, administration of active ingredients and for preventing or treating dysmenorrhea |
| 08/26/2004 | US20040166176 Side effect reduction; reducing pain; synergistic mixture containing muscle relaxants; administering prostaglandins |
| 08/26/2004 | US20040166171 Antiulcer agents; anaerobic infections |
| 08/26/2004 | CA2513716A1 Piperazine-2-carboxamide derivatives |
| 08/26/2004 | CA2513220A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 08/26/2004 | CA2512989A1 Screening and treatment methods for prevention of preterm delivery |
| 08/25/2004 | EP1449844A1 benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1448790A2 Methods and compositions for treating cancer |
| 08/25/2004 | EP1448592A1 Steroidal compounds for inhibiting steroid sulphatase |
| 08/25/2004 | EP1448591A1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 08/25/2004 | EP1448589A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 08/25/2004 | EP1448562A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 08/25/2004 | EP1448557A2 Heteroindanes: a new class of potent cannabimimetic ligands |
| 08/25/2004 | EP1448544A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 08/25/2004 | EP1448542A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 08/25/2004 | EP1448537A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 08/25/2004 | EP1448531A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448521A1 Derivatives of andrimide and moiramide b having antibacterial properties |
| 08/25/2004 | EP1448207A1 Dosage regimen and pharmaceutical composition for emergency contraception |
| 08/25/2004 | EP1448194A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| 08/25/2004 | EP1448186A1 Medicament for the treatment of viral skin and tumour diseases |
| 08/25/2004 | EP1448184A1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie s disease |
| 08/25/2004 | EP1448178A1 Prevention of miscarriage with immunomodulating non-endogenous gestagen compounds |
| 08/25/2004 | EP1448175A1 Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate |
| 08/25/2004 | EP1448150A2 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 08/25/2004 | EP1347963B1 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
| 08/25/2004 | EP1212067A4 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 08/25/2004 | EP1169337B1 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
| 08/25/2004 | EP1087963B1 Inhibitors of glycogen synthase kinase 3 |
| 08/25/2004 | EP1083903B1 Bridged indenopyrrolocarbazoles |
| 08/25/2004 | EP1025094B1 Substituted indan derivatives |
| 08/25/2004 | EP0830130B1 Tnf-alpha converting enzyme |
| 08/25/2004 | CN1524082A Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523012A Novel use of acetamide derivative |
| 08/25/2004 | CN1522762A Adjuvant free GRH antibody polypeptide vaccine and its preparation method |
| 08/25/2004 | CN1522754A Extraction of antiviral immune matter for curing sexual disorder and its formulation |
| 08/25/2004 | CN1522740A Hemiplegia hypertension and contraceptive treating plaster |
| 08/25/2004 | CN1522728A Female health granule preparation method |
| 08/25/2004 | CN1163466C Substituted oxobutyric acid derivative as matrix metalloprotease inhibitor |
| 08/25/2004 | CN1163239C Medicine for treating gynopathy |
| 08/25/2004 | CN1163230C Remedial agent for erectile dysfunction |
| 08/25/2004 | CN1163222C Drug delivery system for releasing two or more active substance |
| 08/24/2004 | US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide |
| 08/24/2004 | US6780884 Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780867 Thienopyrimidines |
| 08/24/2004 | US6780862 Such as amino-indazoles for treatment of central nervous system disorders |
| 08/24/2004 | US6780854 Orally active androgens |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/24/2004 | US6780640 Human carboxypeptidases and polynucleotides encoding the same |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
| 08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |
| 08/24/2004 | CA2285733C Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof |
| 08/19/2004 | WO2004069820A1 Coumarin derivatives having an affinity for oestrogen receptors, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069271A1 Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis |
| 08/19/2004 | WO2004069260A1 Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 08/19/2004 | WO2004069232A2 Egfr tyrosine kinase inhibitor for treating cardiovascular dysfunction |
| 08/19/2004 | WO2004043994A3 A retro-inverso gonadotropin-releasing hormone peptide and vaccine composition |
| 08/19/2004 | WO2003077834A3 Central airway administration for systemic delivery of therapeutics |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | US20040162355 Methods of treating and preventing cerebral function disorders using sibutramine metabolites |
| 08/19/2004 | US20040162304 Estrogen receptor modulators |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162274 Inhibition of steroid synthesis by use of progesterone or a progesterone receptor agonist |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040161825 Sperm specific proteins |
| 08/19/2004 | US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 08/19/2004 | US20040161745 Nucleotide sequences coding glucuronidase for identifying modulators for treatment of inflammation; wound healing agents and tissue repair |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |